Table 7.
Comparison of baseline data between the HBsAg seroclearance and HBsAg non-seroclearance groups.
| Baseline characteristics | HBsAg seroclearance group | HBsAg non-seroclearance group | P |
|---|---|---|---|
| (N = 61) | (N = 25) | (N = 36) | |
| Gender | |||
| Male | 13 | 22 | 0.479 |
| Female | 12 | 14 | |
| Age (year) | 41 ± 8 | 44 ± 9 | 0.165 |
| HBsAg (IU/ml) | 57.01 (2.91–204.49) | 236.61 (11.46–699.14) | 0.032 |
| DNA (IU/ml) | 20 (20–37.5) | 35 (20–100) | 0.218 |
| ALT (U/L) | 21 (17–35) | 23 (19–35) | 0.607 |
| AFP (ng/ml) | 2.43 (1.925–3.140) | 2.400 (1.818–3.018) | 0.538 |
| TB (μmol/L) | 12.5 (8.7–14.0) | 12.0 (9.4–16.10) | 0.719 |
| P (mmol/L) | 1.09 (1.005–1.150) | 1.05 (1.00–1.14) | 0.480 |
| Cr (μmol/L) | 84 ± 20 | 83 ± 16 | 0.789 |
| CK (U/L) | 133 (106–268) | 136 (97–188) | 0.449 |
| FGB (mmol/L) | 5.1 (4.9–5.4) | 5.5 (5.1–5.7) | 0.017 |
HBsAg, hepatitis B surface antigen; DNA, deoxyribonucleic acid; ALT, alanine aminotransferase; AFP, alpha fetoprotein; TB, total bilirubin; P, phosphorus; Cr, creatinine; CK, creatine kinase; FGB, fasting blood sugar.